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ABSTRACT
Objectives To evaluate the real-life effect of an
evidence-based Gold Standard Programme (GSP) for
smoking cessation interventions in disadvantaged
patients and to identify modifiable factors that
consistently produce the highest abstinence rates.
Design Observational prospective cohort study.
Setting GSPs in pharmacies, hospitals and communities
in Denmark, reporting to the national Smoking Cessation
Database.
Participants Disadvantaged patients, defined as
patients with a lower level of education and those
receiving unemployment benefits.
Interventions 6-week manualised GSP smoking
cessation interventions performed by certified staff.
Main outcome measures 6 months of continuous
abstinence, response rate: 80%.
Results Continuous abstinence of the 16 377 responders
was 34% (of all 20 588 smokers: 27%). Continuous
abstinence was lower in 5738 smokers with a lower
educational level (30% of responders and 23% of all) and
in 840 unemployed (27% of responders and 19% of all).
In respect to modifiable factors, continuous abstinence
was found more often after programmes in one-on-one
formats (vs group formats) among patients with a lower
educational level, 34% (vs 25%, p¼0.037), or among
unemployed, 35% (vs 24%, p¼0.099). The variable
‘format’ stayed in the final model of multivariable
analyses in patients with a lower educational level,
OR¼1.31 (95% CI 1.05 to 1.63).
Conclusions Although continuous abstinence was
lower among disadvantaged smokers, the absolute
difference was small. If the programme had been as
effective in disadvantaged as in non-disadvantaged
groups, there would have been an extra 46 or 8 quitters
annually, respectively. Promoting individual interventions
among those with a low education may increase the
effectiveness of GSP.
INTRODUCTION
Smoking rates are higher among individuals from
lower socioeconomic groups. Access to preventive
health services, such as smoking cessation
programmes, is limited, and the success rate is
reported to be even smaller.1e4 The efﬁcacy of
smoking cessation interventions in research
settings has been described in randomised clinical
trials.4e10 There have been few studies of the
effectiveness of interventions implemented in real-
life settings, thus results from efﬁcacy trials might
not reﬂect real-life conditions.11 12
The Danish Smoking Cessation Database (SCDB-
DK) offers a unique opportunity to analyse the
effectiveness of real-life smoking cessation inter-
ventions.13 14 This high-quality clinical database
combines comprehensive information on 67 000
smoking interventions taking place at the smoking
cessation intervention units. Smokers have been
included from 2001 and are followed up to 6 months
after the intervention. The SCDB-DK reﬂects
a diversity of settings, formats and organisations.
The main programme is the Gold Standard
Programme (GSP).15e17 In order to further address
smoking-related inequality in healthcare, we must
know which programmes are most effective for the
disadvantaged. The data set also allowed exploration
of factors that might be modiﬁed in order to increase
continuous abstinence among disadvantaged
groups, such as the programme setting payment and
modality, as well as more traditional factors such as
age or gender which might affect outcome but are
not modiﬁable. We were not aware of any current
literature addressing these issues. In general, there is
some evidence that group programmes are more
effective7 18 and that incentives have a short effect
but no consistent long-term effect.19 With regard to
geography, Denmark is a very small country with
a good infrastructure, and the capital is not far from
the regions. The Danes travel back and forth
between regions every day; therefore, another region
for smoking cessation intervention could easily be
chosen. Therefore, the geographical region was
considered a potentially modiﬁable factor, although
this might not always be the case.
Thus, the aim of this study was to identify the
programme, setting, payment modality and
geographic region with the highest rates of
continuous abstinence in disadvantaged patients.
METHODS
Design
This was an observational prospective cohort study
using data from a national registry (Smoking
Cessation Database).
Setting
During the study period, smoking cessation
programmes were offered in all ﬁve Danish regions
by more than 350 units in hospitals and primary
care facilities, including pharmacies, municipality
facilities and others.
Participants
From the beginning of 2001 to the summer of
2011, approximately 67 000 smoking cessation
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interventions were registered in the Smoking Cessation Data-
bank. Informed consent was obtained. From 2006, registration
was performed using a unique 10 digit personal identiﬁcation
number (PIN), and 34 551 interventions were registered with
a PIN at the end of January 2011. The PIN can be used to control
for doublets. Individuals, who registered in the Smoking
Cessation Database, were at least 18 years old, and participated
in the GSP in Denmark were included. Patients younger than
18 years (411 patients); patients from Greenland (37 patients);
patients without information on gender, age and smoking
cessation unit (53 patients); patients with <7-month follow-up
(1723 patients) and patients attending interventions other
than the GSP (2522 patients) were excluded. Thereby, 29 805
smoking cessation interventions according to GSP were consid-
ered. Some smoking cessation units did not systematically
follow their patients up to 6 months. Patients in those units
were not included in the analysis of the primary outcome (trial
proﬁle: ﬁgure 1). Of the 21 516 databank entries ﬁnally included,
seven were double entries and 921 were entries referring to
courses of patients attending a programme more than one time
(two to seven times). Therefore, 20 588 patients were ﬁnally
included.
Intervention
The GSP has been the standard intervention in Denmark since
2001. It was developed with the guidance of the National
Cancer Institute, which trained the Stop Smoking Centre.20 The
programme consisted of manual-based teaching sessions
together with nicotine replacement therapy.13 14 20 It consisted
of ﬁve meetings over 6 weeks, with a clearly structured patient
education programme, including a motivational conversation at
the beginning, reﬂections on beneﬁts and costs of continuous
smoking versus cessation, date of cessation, teaching and
training about risk situations and relapse prevention, with-
drawal symptoms and medical support, and planning for the
future. Nicotine replacement therapy was provided and adjusted
to smoking severity, according to the Fagerström test21 score, the
number of cigarettes (or gram of tobacco when smoking pipes or
cigars) and patient preferences. The patients were free to choose
different kinds of nicotine products and change their minds
during the programme. A hotline was available during daytime
hours on working days. GSP was delivered either in a group or in
an individual format. The group size varied, with the median
being 12 registered participants (range 2e26 participants). The
allocation of a single patient to the group or individual
Figure 1 Patient flow. FU, follow-up;
GSP, Gold Standard Smoking Cessation
Programme; SCI, smoking cessation
intervention.
Table 1 Continuous abstinence rates; OR and 95% CI for the univariate, adjusted analysis and for the final multivariable model
Variables













Capital vs other regions 0.88 (0.78 to 1.00) 0.95 (0.83 to 1.11) 1.11 (0.77 to 1.59) 1.39 (0.90 to 2.15)
Setting
Pharmacy vs other 1.08 (0.93 to 1.24) 0.99 (0.84 to 1.17) 0.89 (0.58 to 1.37) 0.85 (0.52 to 1.41)
Hospital vs other 0.97 (0.79 to 1.19) 1.01 (0.79 to 1.30) 0.64 (0.39 to 1.07) 0.57 (0.30 to 1.09)
Individual format vs other 1.25 (1.01 to 1.54) 1.30 (1.03 to 1.63) 1.31 (1.05 to 1.63) 1.56 (0.92 to 2.66) 2.02 (1.07 to 3.79)
Free medication for <5 weeks 1.14 (0.93 to 1.40) 1.17 (0.92 to 1.48) 0.64 (0.34 to 1.17) 0.78 (0.38 to 1.62)
Men vs women 1.18 (1.03 to 1.34) 1.26 (1.09 to 1.45) 1.25 (1.09 to 1.43) 1.23 (0.85 to 1.79) 1.39 (0.92 to 2.10)
Age, each 10 years 1.07 (1.02 to 1.12) 1.03 (0.97 to 1.09) 1.02 (0.89 to 1.18) 0.99 (0.80 to 1.22)
Pack-year, each 10 years 0.96 (0.93 to 0.99) 1.00 (0.95 to 1.05) 0.93 (0.85 to 1.01) 0.95 (0.82 to 1.11)
Fagerstro¨m, each point 0.88 (0.86 to 0.91) 0.89 (0.86 to 0.92) 0.88 (0.86 to 0.92) 0.89 (0.81 to 0.96) 0.92 (0.82 to 1.03) 0.89 (0.82 to 0.98)
Earlier attempts
1e3/missing vs no attempts 1.06 (0.93 to 1.21) 0.98 (0.85 to 1.13) 1.19 (0.81 to 1.73) 1.06 (0.71 to 1.609)
>3 attempts vs no attempt 0.99 (0.78 to 1.27) 0.83 (0.64 to 1.09) 1.73 (0.90 to 3.31) 1.43 (0.70 to 2.93)
Living with smoker 0.94 (0.82 to 1.08) 1.01 (0.88 to 1.16) 1.10 (0.76 to 1.61) 1.49 (0.98 to 2.26)
Compliant with the programme 3.32 (2.86 to 3.86) 3.26 (2.80 to 3.80) 3.30 (2.84 to 3.84) 4.60 (3.05 to 6.95) 4.59 (2.99 to 7.05) 4.58 (3.01 to 6.96)
Professional recommendation 0.78 (0.69 to 0.89) 0.79 (0.69 to 0.91) 0.80 (0.70 to 0.92) 0.70 (0.49 to 1.02) 0.91 (0.60 to 1.37)
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Table 2 Characteristics of all patients with low and high education and their continuous abstinence (given as % of all and of the responders,
respectively)
Low education High education
Characteristics Continuous abstinence (%) Characteristics Continuous abstinence (%)
n (%) All Responders n (%) All Responders
All 5738 (100) 23 30 14 850 (100) 28 35
Setting
Hospital/midwifery 686 (12) 22 29 1613 (11) 30 36
Pharmacies 1677 (29) 24 31 3537 (24) 30 37
Municipality/county 3320 (58) 22 29 9571 (64) 27 34
Other 55 (1) 129 (1)
Format
Individual 601 (10) 25 34 1240 (8) 32 40
Group 5106 (89) 22 29 13 536 (91) 28 34
Other 31 (1) 74 (0)
Medication for free
No free medication 3135 (55) 23 30 7778 (52) 30 36
Free medication for a few days 1979 (34) 21 28 5806 (39) 26 34
Free medication for <5 weeks 523 (9) 23 31 1065 (7) 27 33
Free medication for 5 weeks 101 (2) 30 41 201 (1) 33 39
Region
Living in the capital 2072 (36) 21 28 6347 (43) 26 33
Living in other regions 3666 (64) 24 31 8503 (57) 30 36
Midtjylland 1207 (21) 25 31 2860 (19) 30 36
Nordjylland 275 (5) 23 30 539 (4) 31 37
Sjælland 891 (16) 24 31 2152 (14) 29 35
Syddanmark 1293 (23) 24 30 2952 (20) 30 36
Gender
Male 2221 (39) 24 32 5715 (38) 31 38
Female 3517 (61) 22 28 9135 (62) 27 33
Age (years)
18e39 1756 (31) 18 27 3588 (24) 26 34
40e49 1237 (22) 24 31 3845 (26) 28 34
50e59 1359 (24) 24 30 4007 (27) 28 35
59e98 1386 (24) 26 32 3410 (23) 31 37
Smoking
0e20 pack-years 2301 (40) 23 31 5515 (37) 30 39
>20 pack-years 3437 (60) 23 29 9335 (63) 27 33
Fagerstro¨m 1e4 points 1968 (34) 28 36 5838 (39) 33 40
Fagerstro¨m 5e10 points 3770 (66) 20 26 9012 (61) 25 32
0 to <10 cigarettes per day 487 (8) 26 35 1328 (9) 36 45
10 to <20 1896 (33) 26 34 5317 (36) 30 37
20 to <30 2415 (42) 22 28 6118 (41) 26 32
30 to <40 647 (11) 17 23 1460 (10) 24 30
40+ 293 (5) 18 24 627 (4) 23 29
Compliance with programme
Compliant 3200 (56) 32 39 8970 (60) 37 44
Not compliant 2418 (42) 11 15 5588 (38) 14 18
Missing information 120 (2) 25 33 292 (2) 29 39
Living with a smoker
Yes 2129 (37) 22 29 4910 (33) 28 34
No 3568 (62) 23 30 9825 (66) 29 36
Missing information 41 (1) 29 44 115 (1) 30 36
Attempts to quit
Never attempting to quit 2516 (44) 22 29 5535 (37) 28 34
1e3 2724 (47) 23 30 7506 (51) 28 34
>3 438 (8) 23 29 1488 (10) 33 41
Missing information 60 (1) 22 30 321 (2) 23 32
Professional recommendation
Yes 3345 (58) 21 28 8113 (55) 27 33
No 2393 (42) 25 33 6737 (45) 30 37
Education
Low level 5738 (100) 23 30
High level 14 082 (95) 29 35
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programme was at the discretion of the smoking cessation units
or the instructors, respectively. The programme was usually
offered free of charge. Of the 20 588 patients, 19 185 (93%)
received the course for free. Some patients received free
medication, while others had to pay themselves.
According to the standard operating procedures deﬁned by the
Steering Committee, compliance was deﬁned as attendance of
75% or more of the scheduled meetings.
Measures (including outcome and independent variables)
Outcomes
The primary outcome was continuous abstinence, deﬁned as not
smoking at all from the end of the programme to the 6-month
follow-up, as reported in a telephone interview after 6 months
61 month. Four attempts were made to reach the patient, and
at least one attempt had to be in the evening.
Other variables
For every patient, the smoking cessation programme, the speciﬁc
modiﬁcations (individual vs group format), the region (Capital
of Copenhagen, Midtjylland, Nordjylland, Sjælland, Syddan-
mark), the payment modality (no free medication, free medi-
cation for a few days, free medication for <5 weeks or 5-week
medication free of charge) and the setting (hospitals, pharmacies
and county or municipality) were documented categorically. If
there were missing data, for the purpose of the multivariable
analyses, dummy variables were formed and the missing vari-
ables were summarised as shown in the ﬁrst column of table 1.
The continuous variables such as age, smoking (cigarettes per
day, pack-years (years of smoking 3 cigarettes per day divided
by 20)) and Fagerström Test for Nicotine dependence21 were
categorised as shown in tables 2 and 3.
Accordingly, quit attempts (never, one to three attempts or at
least three attempts or missing information), living with
a smoker (vs not living with a smoker or missing information),
compliance (attendance of 75% or more of the scheduled
meetings), non-compliant with programme (<75%) or missing
information on compliance were documented for every patient.
All patients were asked whether they received a recommenda-
tion from a health professional (eg, doctor, nurse, midwife).
There was no difference made between those with no profes-
sional recommendation and those not responding to the
question concerning professional recommendation.
Lower educational level was deﬁned as no education except
school (up to 12 years) or only short work-related courses in
contrast to all other levels of education. Unemployment was
deﬁned as being available for the labour market and receiving
unemployment beneﬁts from the state, the municipalities,
insurance or the unions. People at home, retired patients or
patients in school were not included in this group; the propor-
tion of patients without information on unemployment and
education (4% and 3%, respectively (tables 2 and 3) was
considered small and acceptable for a real-life study.
Statistical analysis
Existing data were analysed and reported, including missing
data, loss of follow-up and sensitivity analyses according to the
STROBE22 recommendations. First, a general description of the
sample was given together with a description of the non-
responders and the responders. Then, continuous abstinence was
reported based on the patients’ responses. Most randomised
studies addressing the effect of smoking cessation intervention
usually report according to the Russell Standards,23 which
assume that it is likely that non-responders have relapsed.
Therefore, continuous abstinence was also reported in our study,
assuming that non-responders had relapsed.
The estimate of the expected annual number of extra quitters
was calculated by multiplying the absolute differences in
continuous abstinence rate with the number of the responding
patients in this subgroup and by dividing it with the number of
years of observation (5 years).
The continuous variables mentioned above were used in the
multivariable analyses. Age, pack-years and cigarettes per day
were included in steps of 10 (years or cigarettes).
The c2 test or exact methods were used in the analysis of
categorical data. A two-sided p value of <0.05 was regarded as
signiﬁcant. The non-parametric ManneWhitney U test for the
comparison of continuous or almost continuous variables was
used. Multivariable logistic regression analyses and analyses of
variance were used to test for differences in continuous absti-
nence. Statistical signiﬁcances of possible predictors of contin-
uous abstinence were compared by calculating the OR and the
corresponding 95% CIs. Multiple logistic regression analyses
were performed by entering all predictors together, followed by
a stepwise backward procedure p(in) <0.10.
Dummy variables were formed for the variables as outlined in
table 1 for the purpose of multivariable analysis (eg, capital vs
regions, individual programme format, payment modality, living
with a smoker, compliance, etc). The items ‘other ’ or ‘missing’
were added to the bigger group. These numbers were considered
as small and acceptable for a real-life study.
All statistical calculations were done with PASW V.18 (IBM
Corporation).
RESULTS
The analysis at 6 months for continuous abstinence included
both the 16 377 responders (80%) and the 20% of non-
responders (4211 patients). As shown in table 4, responding
patients differ mainly with respect to age and compliance from
non-responding patients. Non-responders were 3 years younger
(median 47.3 vs 50.4 years, p<0.001). Patients compliant with
the programme were more likely to respond: proportion of non-
responders were lower among compliant patients compared to
non-compliant patients (16% vs 27%, p<0.001). Rates of non-
responding were 23% for those with a lower educational level
and 28% for the unemployed. The proportion of non-responders
Table 2 Continued
Low education High education
Characteristics Continuous abstinence (%) Characteristics Continuous abstinence (%)
n (%) All Responders n (%) All Responders
Unemployment
Unemployed 371 (6) 16 24 469 (3) 22 29
Not unemployed 5282 (92) 23 30 13 951 (94) 29 35
Missing information 85 (1) 21 31 430 (3) 23 31
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Table 3 Characteristics of the unemployed and not unemployed patients and their continuous abstinence (given as % of all and of the responders,
respectively)
Unemployed Not unemployed
Characteristics Continuous abstinence (%) Characteristics Continuous abstinence (%)
n (%) All Responders n (%) All Responders
All 840 (100) 19 27 19 748 (100) 27 34
Setting
Hospital/midwifery 145 (17) 17 21 2154 (11) 28 35
Pharmacies 219 (26) 19 27 4995 (25) 29 36
Municipality/county 473 (56) 21 29 12 418 (63) 26 33
Other 3 (0) 181 (1)
Format
Individual 99 (12) 24 35 1742 (9) 30 38
Group 734 (87) 19 26 17 908 (91) 27 33
Other 7 (1) 98 (0)
Medication for free
No free medication 444 (53) 20 29 10 469 (53) 28 35
Free medication for a few days 295 (35) 20 27 7490 (38) 25 33
Free medication for <5 weeks 92 (11) 12 17 1496 (8) 27 33
Free medication for 5 weeks 9 (1) 33 38 293 (1) 32 40
Region
Living in the capital 337 (40) 21 28 8082 (41) 25 32
Living in other regions 503 (60) 18 26 11 666 (59) 28 35
Midtjylland 208 (25) 20 27 3859 (20) 29 35
Nordjylland 41 (5) 22 29 773 (4) 29 35
Sjælland 113 (13) 18 26 2930 (15) 28 34
Syddanmark 141 (17) 16 24 4104 (21) 28 35
Gender
Male 304 (36) 21 30 7632 (39) 29 36
Female 536 (64) 19 26 12 116 (61) 26 32
Age (years)
18e39 361 (43) 18 27 4983 (25) 24 32
40e49 209 (25) 20 28 4873 (25) 27 34
50e59 233 (28) 21 26 5133 (26) 28 34
59e98 37 (4) 19 23 4759 (24) 29 36
Smoking
0e20 pack-years 381 (45) 19 30 7435 (38) 28 37
>20 pack-years 459 (55) 19 25 12 313 (62) 26 32
Fagerstro¨m 1e4 points 227 (27) 23 33 7579 (38) 32 39
Fagerstro¨m 5e10 points 613 (73) 178 25 12 169 (62) 24 30
0 to <10 cigarettes per day 60 (7) 18 27 1755 (9) 34 43
10 to <20 252 (30) 27 39 6961 (35) 29 36
20 to <30 360 (43) 17 24 8173 (41) 25 32
30 to <40 111 (13) 14 18 1996 (10) 22 29
40+ 57 (7) 14 16 863 (4) 22 28
Compliance with programme
Compliant 396 (47) 32 40 11 774 (60) 36 43
Not compliant 426 (51) 8 13 7580 (38) 13 18
Missing information 18 (2) 6 10 394 (2) 29 38
Living with a smoker
Yes 292 (35) 20 28 6747 (34) 26 32
No 545 (65) 19 26 12 848 (65) 27 35
Missing information 3 (0) 158 (1)
Attempts to quit
Never attempted to quit 418 (50) 18 25 7633 (39) 26 33
1e3 350 (42) 20 28 9880 (50) 27 33
>3 attempts 68 (8) 25 36 1858 (9) 31 38
Missing information 4 (0) 377 (2) 23 32
Professional recommendation
Yes 531 (63) 18 24 10 927 (55) 26 32
No 309 (37) 21 32 8821 (45) 29 36
Education
Low level 371 (44) 16 24 5367 (27) 23 30
High level 446 (53) 23 30 13 636 (69) 29 36
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was between 18% and 23% for all other socio-demographic-,
smoking- and intervention-related variables.
Overall, 34% (5503 of 16 377 patients) reported 6 months of
continuous abstinence. Continuous abstinence was 27%, when
all non-responders were considered to be smokers. Of the 16 377
responding to follow-up, 27% had a lower level of education and
4% were unemployed (ﬁgure 1). The characteristics of all of the
patients with respect to unemployment or level of education are
shown in tables 2 and 3.
Continuous abstinence was signiﬁcantly lower for the patients
with a lower education level (30%) compared with those with
a higher education level (35%, p<0.001) in those responding (of
all registered: 23% vs 28%, table 2). Continuous abstinence was
also signiﬁcantly lower for the unemployed patients (27%)
compared with those who were employed (34%, p<0.001),
corresponding to 19% versus 27% of all registered (table 3).
The overall difference in continuous abstinence between
disadvantaged and non-disadvantaged patients was 5% (with
respect to education) and 7% (with respect to unemployment).
The difference was up to 11% (with respect to high vs low
education in patients with three or more quit attempts) or 15%
with respect to unemployment (vs non-unemployed) in patients
receiving free medication for <5 weeks and 12% in the patients
59 years and older as well as in those smoking <10 cigarettes per
day (16%) or more than 40 cigarettes per day (12%). Comparing
disadvantaged patients with non-disadvantaged patients, the
most striking difference was observed in respect to employment
in the hospital setting: continuous abstinence was 14% higher in
non-unemployed patients compared with unemployed patients.
The characteristics and percentage of the disadvantaged
patients with continuous abstinence are shown in tables 2 and
3. The results of the univariate and multivariable analyses for
the 6-month continuous abstinence rate are shown in table 1.
The ﬁnal model revealed that the lower Fagerström Test for
Nicotine Dependence Score21 (per point) and compliance with
the programme were the only consistent predictors associated
with continuous abstinence in both groups of disadvantaged
patients.
For patients with the lower educational level, the variable
‘individual format’ of the GSP was a predictor of success in
smoking cessation (OR¼1.31, 95% CI 1.05 to 1.63), but for
unemployed patients, it did not remain in the ﬁnal model.
In the group of patients with a lower educational level, male
gender or not having received a recommendation to quit by
a health professional were also predictors for continuous
abstinence.
DISCUSSION
Among disadvantaged smokers participating in the Danish GSP
for smoking cessation, we can report relatively high continuous
abstinence rates of those responding (27%e30%) and 19%e23%
of all registered for treatment. However, this is still 5%e7%
lower than non-disadvantaged smokers. In absolute terms, there
would be eight extra quitters per year if the programme was as
effective for the unemployed group as it was for the employed
smokers and 46 extra quitters per year for the patients with
a lower level of education. Nine of 10 patients received group
GSP, but continuous abstinence was somewhat higher among
the one-tenth of patients who participated in a programme with
an individual format, regardless of being disadvantaged. No
other potentially modiﬁable component of greater effectiveness
for disadvantaged patients was identiﬁed. It was impossible to
draw ﬁrm conclusions about the effect of payment for medica-
tion, as there were too few patients in the subgroup that
received free medication for <5 weeks or longer. In nearly all
subgroups, there was a consistent and varying lower rate of
continuous abstinence in disadvantaged patients. Interestingly,
in the hospital setting, continuous abstinence was 14% lower in
unemployed patients compared with non-unemployed patients.
The proportion of patients not responding to follow-up was
moderate, and the sensitivity analysis revealed relatively robust
ﬁndings. It should be emphasised again that the Russell criteria23
were not applicable in this registry-based cohort study.
To our knowledge, continuous abstinence of disadvantaged
patients, with regard to the format, the setting, the region and
payment modality, have not been reported in randomised clinical
trial or in cohort studies. Most of the evidence about smoking
cessation derives from randomised trials, but it is regrettable that
up to six of 10 patients with nicotine dependence were not eligible
for these studies because they fulﬁlled at least one exclusion
criteria.12 In contrast to studies applying stricter inclusion
criteria,11 12 24 25 our study included patients aged 18 years or older
undergoing the GSP in Denmark, regardless of smoking severity,
motivation to quit, comorbidity or whether a quit date were set.
In the UK, smoking cessation services have been successfully
implemented in deprived areas, but low long-term cessation
rates in the range of 5%e11% were reported, even though these
studies included quitters at 4 weeks, exclusively.2 6 24 In the UK,
only 3% of all patients were in group programmes,9 24e26 which
had a higher success rate.9 24 26 Many obstacles to attendance
have been identiﬁed in the UK, for example, difﬁculties in
ﬁnding adequate transport in rural areas or reported time
constraints. All of this does not seem to play a major role for
Danish patients. Patients who participated in a programme with
an individual format showed a favourable outcome regardless of
being disadvantaged. It remains unclear whether this ﬁnding is
primarily related to patient preferences or staff competencies.
Those 10%e12% entering the individual format might be
a selected subgroup beneﬁting substantially from the individu-
alised approach. Other factors not sufﬁciently addressed, such as
comorbidity, patient resources or motivation or the patient’s
ability to recall events in the past, such as a health professional’s
recommendation to quit, might be also important in the context
of continuous abstinence after the programme.
Table 3 Continued
Unemployed Not unemployed
Characteristics Continuous abstinence (%) Characteristics Continuous abstinence (%)
n (%) All Responders n (%) All Responders
Unemployment
Unemployed 840 (100) 19 27
Not unemployed 19 233 (97) 27 34
Missing information 515 (3) 23 31
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This is a real-life nationwide evaluation of continuous absti-
nence in disadvantaged smokers undergoing the GSP. It has been
estimated that the Smoking Cessation Database includes about
90% of all registered smoking cessation activities in Denmark,
and more than 5% of all Danish smokers have been registered in
the database to date.27
The proportion of unemployed patients included in our study
(4%) can be considered representative for Denmark (3%e6%),28
suggesting that they were sufﬁciently reached.
However, patients with a lower educational level seemed to
have been under-represented: in our study, there were 27%
compared with 37% in the Danish population.29
The deﬁnition of disadvantaged in the present study can only
be seen in the context of Danish society, and caution is needed if
conclusions are drawn for societies with a different social system
to that of Denmark. The discrepancies between disadvantaged
and higher social classes might be more pronounced in other
societies, as the degree of social consensus is relatively high in
Denmark. One has to keep in mind that all outcome data rely
on self-reporting, thus estimates of continuous abstinence may
be too high. The difference between co-validated and self-
reported continuous abstinence is reported to be between 3%
and 6%.8 24 25 30
It seems that the GSP might overcome at least, to some
degree, the inequity related to disadvantaged smokers. The
major implication for clinicians would be to refer more disad-
vantaged patients to the GSPs. It is important for policy makers
to ensure that disadvantaged patients do get access to these
successful programmes. Promoting individual interventions
among those with low education may increase the effectiveness
of GSP. Future research should focus on how to bring more
patients into smoking cessation intervention programmes. The
dominating predictor for continuous abstinence was compliance
for the disadvantaged as well as for the non-disadvantaged
patient; however, the direction of causality for compliance
cannot be addressed by this approach. Future research should
also address the improvement of compliance and the role of
pharmacies in the care of disadvantaged smokers.
Contributors HT and TN were responsible for the study concept and design. Staff
from the smoking cessation units in Denmark collected the data. MR coordinated the
data collection and processing. TN, BLH, NG and HT did the statistical analyses. All
authors contributed to the interpretation of the analyses and the results. TN and HT
wrote the article. BLH, MR and NG revised it. All authors approved the final edition. All
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Table 4 Patient characteristics with respect to response
All Non-responding (%) Responding (%)
N 20 588 4211 (100%) 16 377 (100%)
Setting
Hospital/midwifery 2299 10 11
Pharmacies 5214 25 25
Municipality/county 12 891 64 62
Other and missing information 184 0 1
Format
Individual 1841 9 9
Group 18 642 90 91
Other and missing information 105 0 1
Medication for free
No free medication 10 913 50 54
Free medication for a few days 7785 41 37
Free medication for <5 weeks 1588 8 8
Free medication for 5 weeks 302 1 1
Region
Living in the capital 8419 45 40
Living in other regions 12 169 55 60
Midtjylland 4067 17 20
Nordjylland 814 4 4
Sjælland 3043 15 15
Syddanmark 4245 19 21
Gender
Male 7936 39 39
Female 12 652 61 61
Age (years)
18e39 5344 32 24
40e49 5082 25 25
50e59 5366 24 27
59e98 4796 20 24
Smoking
0e20 pack-years 7816 43 37
>20 pack-years 12 772 57 63
Fagerstro¨m 1e4 points 7806 36 38
Fagerstro¨m 5e10 points 12 782 64 62
0 to <10 cigarettes per day 1815 9 9
10 to <20 7213 34 35
20 to <30 8533 41 42
30 to <40 2107 11 10
40+ 920 5 4
Compliance with programme
Compliant 12 170 47 62
Not compliant 8006 51 36
Missing information 412 2 2
Living with a smoker
Yes 7039 33 35
No 13 393 66 65
Missing information 156 1 1
Attempts to quit
Never attempted to quit 8051 40 39
1e3 attempts 10 230 49 50
>3 attempts 1926 9 10
Missing information 381 2 2
Professional recommendation
Yes 11 458 54 56
No 9130 46 44
Education
Low level 5738 32 27
High level 14 082 64 70
Missing information 768 4 4
Unemployment
Unemployed 840 6 4
Not unemployed 19 233 91 94
Missing information 515 3 2
What is already known on this subject
Lower socioeconomic groups have higher smoking rates and less
often access to preventive health services such as smoking
cessation intervention programmes.
What this study adds
The GSP is effective in disadvantaged patients almost to the
same degree as in non-disadvantaged patients. Minor improve-
ments may be achieved through modifications of the programme
that is a change from a group to an individual format.
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